Overview

Dose-effect Relationship of Rt-PA on ICH Evacuation

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the optimal dose of rt-PA in the treatment of intracerebral hemorrhage (ICH) using a combination of minimally invasive surgery and clot lysis with rt-PA。
Phase:
Phase 2
Details
Lead Sponsor:
Tongji Hospital
Treatments:
Plasminogen
Tissue Plasminogen Activator